Eesti - eesti - Ravimiamet

livisto int'l s.l. - prednisoloon+mikonasool+polümüksiin b - kõrvatilgad, suspensioon - 5mg+23mg+5500rÜ 1ml 15ml 1tk

Eesti - eesti - Ravimiamet

first pharma oÜ - tselekoksiib - kõvakapsel - 200mg 30tk; 200mg 10tk; 200mg 90tk; 200mg 50tk; 200mg 40tk; 200mg 20tk; 200mg 100tk

Eesti - eesti - Ravimiamet

accord healthcare b.v. - tselekoksiib - kõvakapsel - 200mg 60tk; 200mg 40tk; 200mg 1tk; 200mg 50tk; 200mg 10tk; 200mg 30tk

Eesti - eesti - Ravimiamet

accord healthcare b.v. - tselekoksiib - kõvakapsel - 100mg 10tk; 100mg 20tk; 100mg 100tk; 100mg 40tk; 100mg 50tk; 100mg 30tk; 100mg 60tk; 100mg 1tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

gedeon richter plc. - relugolix, norethisterone acetate, estradiol hemihydrate - leiomüoom - hüpofüüsi ja hüpotaalamuse hormoonid ja analoogid - ryeqo is indicated in adult women of reproductive age for:- treatment of moderate to severe symptoms of uterine fibroids,- symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis.

Euroopa Liit - eesti - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - asatsitidiin - leukeemia, müeloidne, äge - antineoplastilised ained - onureg is indicated as maintenance therapy in adult patients with acute myeloid leukaemia (aml) who achieved complete remission (cr) or complete remission with incomplete blood count recovery (cri) following induction therapy with or without consolidation treatment and who are not candidates for, including those who choose not to proceed to, hematopoietic stem cell transplantation (hsct).

Eesti - eesti - Ravimiamet

first pharma oÜ - tselekoksiib - kõvakapsel - 200mg 30tk

Eesti - eesti - Ravimiamet

ideal trade links uab - tselekoksiib - kõvakapsel - 200mg 20tk

Eesti - eesti - Ravimiamet

ideal trade links uab - tselekoksiib - kõvakapsel - 200mg 30tk; 200mg 20tk; 200mg 100tk; 200mg 40tk; 200mg 50tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

takeda pharmaceuticals international ag ireland branch - maribavir - tsütomegaloviiruse infektsioonid - viirusevastased ravimid süsteemseks kasutamiseks - livtencity is indicated for the treatment of cytomegalovirus (cmv) infection and/or disease that are refractory (with or without resistance) to one or more prior therapies, including ganciclovir, valganciclovir, cidofovir or foscarnet in adult patients who have undergone a haematopoietic stem cell transplant (hsct) or solid organ transplant (sot). tuleks arvesse võtta ametlikke juhiseid sobiva kasutamise kohta viirusevastane ained.